SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-24-007621 to ACHIEVE LIFE SCIENCES, INC. (ACHV) (CIK 0000949858) (ACHV)

ACHIEVE LIFE SCIENCES, INC. (ACHV) (CIK 0000949858)
Date: July 3, 2024 · CIK: 0000949858 · Accession: 0000000000-24-007621

AI Filing Summary & Sentiment

File numbers found in text: 333-280585

Date
July 3, 2024
Author
Not clearly detected
Form
UPLOAD
Company
ACHIEVE LIFE SCIENCES, INC. (ACHV) (CIK 0000949858)

Letter

July 3, 2024 Jon Bencich Chief Executive Officer Achieve Life Sciences, Inc. 22722 29th Drive SE, Suite 100 Bothell, WA 98021 Re:Achieve Life Sciences, Inc. Registration Statement on Form S-3 Filed June 28, 2024 File No. 333-280585 Dear Jon Bencich: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tamika Sheppard at 202-551-8346 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Arielle Trapp

Show Raw Text
July 3, 2024
Jon Bencich
Chief Executive Officer
Achieve Life Sciences, Inc.
22722 29th Drive SE, Suite 100
Bothell, WA 98021
Re:Achieve Life Sciences, Inc.
Registration Statement on Form S-3
Filed June 28, 2024
File No. 333-280585
Dear Jon Bencich:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that
the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Tamika Sheppard at 202-551-8346 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Arielle Trapp